chr5-36671051-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_004172.5(SLC1A3):c.342G>A(p.Lys114=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000849 in 1,613,968 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0046 ( 8 hom., cov: 32)
Exomes 𝑓: 0.00046 ( 10 hom. )
Consequence
SLC1A3
NM_004172.5 synonymous
NM_004172.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.46
Genes affected
SLC1A3 (HGNC:10941): (solute carrier family 1 member 3) This gene encodes a member of a member of a high affinity glutamate transporter family. This gene functions in the termination of excitatory neurotransmission in central nervous system. Mutations are associated with episodic ataxia, Type 6. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 5-36671051-G-A is Benign according to our data. Variant chr5-36671051-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 709741.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.46 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4_exome allele frequency = 0.000462 (676/1461666) while in subpopulation AFR AF= 0.0172 (575/33462). AF 95% confidence interval is 0.016. There are 10 homozygotes in gnomad4_exome. There are 323 alleles in male gnomad4_exome subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 695 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC1A3 | NM_004172.5 | c.342G>A | p.Lys114= | synonymous_variant | 4/10 | ENST00000265113.9 | NP_004163.3 | |
SLC1A3-AS1 | XR_007058736.1 | n.76-2340C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC1A3 | ENST00000265113.9 | c.342G>A | p.Lys114= | synonymous_variant | 4/10 | 1 | NM_004172.5 | ENSP00000265113 | P1 | |
SLC1A3-AS1 | ENST00000510740.1 | n.61-2340C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00455 AC: 693AN: 152184Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
693
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00134 AC: 336AN: 251036Hom.: 6 AF XY: 0.00110 AC XY: 149AN XY: 135662
GnomAD3 exomes
AF:
AC:
336
AN:
251036
Hom.:
AF XY:
AC XY:
149
AN XY:
135662
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000462 AC: 676AN: 1461666Hom.: 10 Cov.: 31 AF XY: 0.000444 AC XY: 323AN XY: 727136
GnomAD4 exome
AF:
AC:
676
AN:
1461666
Hom.:
Cov.:
31
AF XY:
AC XY:
323
AN XY:
727136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00456 AC: 695AN: 152302Hom.: 8 Cov.: 32 AF XY: 0.00481 AC XY: 358AN XY: 74486
GnomAD4 genome
AF:
AC:
695
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
358
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 24, 2020 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Episodic ataxia type 6 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 17, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at